Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of Bashkortostan
Authors:
Open Access
- 27 October 2020
- journal article
- research article
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 101 (5) , 691-697
Abstract
Aim. To assess the spectrum and frequency of mutations in patients with hereditary breast cancer from the Republic of Bashkortostan. Methods. The material for the study was sections of fresh frozen, formalin-fixed and paraffin-embedded tumor tissue from 100 unrelated patients with a histologically confirmed diagnosis of breast cancer. The study was carried out using two methods: real-time polymerase chain reaction and next-generation sequencing-NGS. Results. By using real-time polymerase chain reaction (PCR), the 5382insC mutation in the BRCA1 gene was detected in 12 cases. By using a next-generation sequencing method (NGS), highly penetrant mutations in BRCA1, BRCA2, CHEK2, PALB2 and RAD50 were revealed in 16 patients. In total, these methods detected mutations in 28 patients. Out of a total of probands in the BRCA1 gene, mutations were detected in 13 patients, that included 12 patients with the 5382insC mutation, and 1 patient with c.3143delG. In the BRCA2 gene, mutations were revealed in 3 patients, of which c.6621_6622del in 2 patients and c.-39-1_-39delGA in 1 patient. Mutations in CHEK2 were detected in 5 patients: c.470TC in 3 patients, c.444+1GA in 2 patients. The 1592delT mutation in PALB2 was found in 4 patients. The c.2157delA mutation in RAD50 was detected in 3 patients. Conclusion. Pathogenic mutations in BRCA1/2, CHEK2, PALB2 and RAD50 were found in 28 patients with a hereditary feature of the disease; the identification of highly penetrant mutations in probands allowed us to determine their relatives, probable carriers of mutations, which were referred for genetic counselling.Keywords
This publication has 15 references indexed in Scilit:
- A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological AnalysisOncology, 2016
- Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countriesJournal of Medical Genetics, 2015
- Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American populationBMC Cancer, 2015
- Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2011
- Non-founder BRCA1 mutations in Russian breast cancer patientsCancer Letters, 2010
- Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancerBreast Cancer Research and Treatment, 2009
- Rad50 c.687delT Does Not Contribute Significantly to Familial Breast Cancer in a French PopulationCancer Epidemiology, Biomarkers & Prevention, 2009
- Evaluation of RAD50 in familial breast cancer predispositionInternational Journal of Cancer, 2006
- RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instabilityCarcinogenesis, 2005
- Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. PetersburgRussian Journal of Genetics, 2005